Table 1.
The statistics of prognostic outcomes in the neuroblastoma dataset
| Prognostic outcomes | Positive prognosis (favorable outcomes to the patient) | Negative prognosis (unfavorable outcomes to the patient) | Unknown prognosis |
|---|---|---|---|
| Presence of IDRF | No: 12 (19%) | Yes: 53 (81%) | |
| Grade of neuroblastic differentiation | Well: 55 (84%) | Poor: 7 (11%) | Unknown: 3 (5%) |
| Presence of metastases | No: 41 (63%) | Yes: 24 (37%) | |
| MKI | Low: 41 (63%) | Intermediate: 17 (26%) | Unknown: 7 (11%) |
| MYCN status | Normal: 45 (69%) | Amplified: 11 (17%) | Unknown: 9 (14%) |
| Mortality (presence/absence of death in 3 years) | No: 56 (86%) | Yes: 9 (14%) |